The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1

Annals of Neurology

Volumn 79, Issue 1, 2016, Pages 144-151

  Castillo Gomez, Esther ^a   Kästner, Anne ^a   Steiner, Johann ^b   Schneider, Anja ^c,d   Hettling, Bilke ^a   Poggi, Giulia ^a   Ostehr, Kristin ^b   Uhr, Manfred ^e   Asif, Abdul R ^f   Matzke, Mike ^b   Schmidt, Ulrike ^e   Pfander, Viktoria ^a   Hammer, Christian ^a   Schulz, Thomas F ^g   Binder, Lutz ^f   Stöcker, Winfried ^h   Weber, Frank ^e   Ehrenreich, Hannelore ^a,d  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^d Deutsche Forschungsgemeinschaft   (Germany)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^f UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^g HANNOVER MEDICAL SCHOOL   (Germany)

^h Institute of Experimental Immunology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AUTOANTIBODY; GREEN FLUORESCENT PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR1 NMDA RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; BRAIN; CEREBROSPINAL FLUID; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; TETANUS; ANIMAL; BLOOD; C57BL MOUSE; EPIDEMIOLOGY; IMMUNOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; ANIMALS; AUTOANTIBODIES; BLOOD-BRAIN BARRIER; BRAIN; FEMALE; HUMANS; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MULTIPLE SCLEROSIS; RECEPTORS, N-METHYL-D-ASPARTATE; SEROEPIDEMIOLOGIC STUDIES;

EID: 84956741655     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.24545     Document Type: Article

References (16)

1. Dahm L, Ott C, Steiner J, et al.; Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol 2014; 76: 82-94.
2. Hammer C, Stepniak B, Schneider A, et al.; Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity. Mol Psychiatry 2013; 19: 1143-1149.
3. Hammer C, Zerche M, Schneider A, et al.; Apolipoprotein E4 carrier status plus circulating anti-NMDAR1 autoantibodies: association with schizoaffective disorder. Mol Psychiatry 2014; 19: 1054-1056.
4. Reiber H, Peter JB,. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 2001; 184: 101-122.
5. Dalmau J, Gleichman AJ, Hughes EG, et al.; Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091-1098.
6. Wandinger KP, Saschenbrecker S, Stoecker W, et al.; Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 2011; 231: 86-91.
7. Piedrahita JA, Zhang SH, Hagaman JR, et al.; Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A 1992; 89: 4471-4475.
8. Zerche M, Weissenborn K, Ott C, et al.; Preexisting serum autoantibodies against the NMDAR subunit NR1 modulate evolution of lesion size in acute ischemic stroke. Stroke 2015; 46: 1180-1186.
9. Broadwell RD, Brightman MW,. Entry of peroxidase into neurons of the central and peripheral nervous systems from extracerebral and cerebral blood. J Comp Neurol 1976; 166: 257-283.
10. Cull-Candy S, Brickley S, Farrant M,. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 2001; 11: 327-335.
11. Hardingham GE, Bading H,. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Nat Rev Neurosci 2010; 11: 682-696.
12. Paoletti P, Bellone C, Zhou Q,. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat Rev Neurosci 2013; 14: 383-400.
13. Montagne A, Barnes SR, Sweeney MD, et al.; Blood-brain barrier breakdown in the aging human hippocampus. Neuron 2015; 85: 296-302.
14. Doss S, Wandinger KP, Hyman BT, et al.; High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types. Ann Clin Transl Neurol 2014; 1: 822-832.
15. Gresa-Arribas N, Titulaer MJ, Torrents A, et al.; Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 2014; 13: 167-177.
16. Planaguma J, Leypoldt F, Mannara F, et al.; Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice. Brain 2015; 138 (pt 1): 94-109.